Wo57Venying , Wang Chenghua, Jin Hajiao, 0i Guoging. Department of Cardiovascular Medicine , The Fist Hospital of Hebei Medical University, Hebei Province , Shijiazhuang 050030 ,ChinaCorresponding author: Oi Guoging, E-mail:g7g7g7 @ 163. comFunding program: Key Research and Development Plan projects in Hebei Province( 20377741D)
【 Abstract】 Direct percutaneous coronary intervention (PPCI) is considered to be the best strategy for reperfusion in
patients with acute ST⁃segment elevation myocardial infarction. Coronary no⁃reflow (NR) phenomenon is characterized by
slow epicardial blood flow or no antegrade blood flow on angiography , but there is no evidence of mechanical vascular obstruc⁃
tion. This phenomenon often leads to insufficient myocardial perfusion and poor prognosis. How to prevent and treat NR is
a major problem to be solved in clinic. In recent years, some drug and non⁃drug methods have been put forward and have a⁃
chieved certain therapeutic effects. This article reviews the progress of NR treatment.
【Key words】 Acute ST⁃segment elevation myocardial infarction; Primary percutaneous coronary intervention; No⁃re⁃
flow; Treatment
Author: Qi Guoqing, E-mail:q7g7q7@163.com;
Received: 2022-10-15
Fund:Key Research and Development Plan projects in Hebei Province(20377741D);